Oncogene - Table of Contents alert Volume 34 Issue 43

If you are unable to see the message below, click here to view.

Advertisement Validated ChIP antibodies you can TRUST – and try a sample! Partnering with epigenetics experts in the BLUEPRINT epigenome consortium, Diagenode has developed completely validated epigenetics antibodies with:   •  The highest specificity and sensitivity available  •  Unparalleled MeDIP, ChIP, and ChIP-seq results  •  Validated, so you have complete confidence in your results Learn more and try a sample today. TABLE OF CONTENTS Volume 34, Issue 43 (October 2015) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. The journal has an Impact Factor of 3.952. Explore the benefits of submitting your next research article: http://bit.ly/1vUuaXe Review Top Review of immune-related adverse events in prostate cancer patients treated with ipilimumab: MD Anderson experience J Gao, Q He, S Subudhi, A Aparicio, A Zurita-Saavedra, D H Lee, C Jimenez, M Suarez-Almazor and P Sharma Oncogene 2015 34: 5411-5417; advance online publication, February 9, 2015; 10.1038/onc.2015.5 Abstract | Full Text Original Articles Top Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis Y G Lin, J Shen, E Yoo, R Liu, H-Y Yen, A Mehta, A Rajaei, W Yang, P Mhawech-Fauceglia, F J DeMayo, J Lydon, P Gill and A S Lee Oncogene 2015 34: 5418-5426; advance online publication, February 16, 2015; 10.1038/onc.2015.4 Abstract | Full Text Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer OPEN S Stolzenburg, A S Beltran, T Swift-Scanlan, A G Rivenbark, R Rashwan and P Blancafort Oncogene 2015 34: 5427-5435; advance online publication, February 16, 2015; 10.1038/onc.2014.470 Abstract | Full Text Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis S L Haney, R A Hlady, J Opavska, D Klinkebiel, S J Pirruccello, S Dutta, K Datta, M A Simpson, L Wu and R Opavsky Oncogene 2015 34: 5436-5446; advance online publication, February 2, 2015; 10.1038/onc.2014.472 Abstract | Full Text Cytoplasmic p27 promotes epithelial–mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation OPEN D Zhao, A H Besser, S A Wander, J Sun, W Zhou, B Wang, T Ince, M A Durante, W Guo, G Mills, D Theodorescu and J Slingerland Oncogene 2015 34: 5447-5459; advance online publication, February 16, 2015; 10.1038/onc.2014.473 Abstract | Full Text Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis J Gong, D Weng, T Eguchi, A Murshid, M Y Sherman, B Song and S K Calderwood Oncogene 2015 34: 5460-5471; advance online publication, February 9, 2015; 10.1038/onc.2015.1 Abstract | Full Text Effects of physiological and synthetic IAP antagonism on c-IAP-dependent signaling A J Kocab, A Veloso, M T Paulsen, M Ljungman and C S Duckett Oncogene 2015 34: 5472-5481; advance online publication, February 9, 2015; 10.1038/onc.2015.3 Abstract | Full Text Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression Q Xu, L-Z Liu, Y Yin, J He, Q Li, X Qian, Y You, Z Lu, S C Peiper, Y Shu and B-H Jiang Oncogene 2015 34: 5482-5493; advance online publication, February 23, 2015; 10.1038/onc.2015.6 Abstract | Full Text GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis G Maric, M G Annis, Z Dong, A A N Rose, S Ng, D Perkins, P A MacDonald, V Ouellet, C Russo and P M Siegel Oncogene 2015 34: 5494-5504; advance online publication, March 16, 2015; 10.1038/onc.2015.8 Abstract | Full Text Short Communication Top A role for Rac1 activity in malignant progression of sebaceous skin tumors D Frances, N Sharma, R Pofahl, M Maneck, K Behrendt, K Reuter, T Krieg, C A Klein, I Haase and C Niemann Oncogene 2015 34: 5505-5512; advance online publication, February 9, 2015; 10.1038/onc.2014.471 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.